New AgaMatrix Jazz DoseCoach
The UK's 1st Basal Insulin Only Advisor1
For type 2 patients on once daily basal insulin only.
ISO 15197:2015 Accuracy
Jazz DoseCoach

Proven to reduce HbA1c without the increased risk of hypo3

For type 2 patients on once daily basal insulin only, JAZZ™ DoseCoach® assists in the self-adjustment of their insulin doses.

It does this using a feature called Dose Helper, which after the HCP determines the starting dose, it safely2 suggests gradual adjustments to the patient's basal insulin dose until their fasting blood glucose readings are within their target range.

The JAZZ DoseCoach incorporates a blood glucose meter with a large memory and uses the same testing strip as the family of JAZZ blood glucose meters, which is on the NHS Drug Tariff at £8.74.

JAZZ DoseCoach devices and activation keys are supplied free of charge to healthcare professionals who have undertaken JAZZ DoseCoach training. Activation keys are available for Lantus and Toujeo glargine insulins and three different treatment plans for each insulin. The device is personalised and activated by inserting the relevant key into the USB port of the DoseCoach and following the simple on-screen instructions.

Activation keys

Once the DoseCoach-trained HCP has personalised and activated the device, it is then ready for the patient to follow the easy steps that will lead to dose adjustment suggestions from day four onwards.

Day 1
Device set up by healthcare professional
Enter your insulin dose
Day 2
Measure your fasting blood glucose
Enter your insulin dose
Day 3
Measure your fasting blood glucose
Enter your insulin dose
Day 4
Measure your fasting blood glucose
First dose suggestion

Dose Helper will suggest on a daily basis, gradual adjustments to the patient's daily basal insulin dose until their fasting blood glucose readings are within the target range.

  • Evidence Based. 16 week AUTOMATIX study3.
  • Effective. There was a trend for patients to achieve target FSMPG faster with JAZZ DoseCoach-supported basal insulin dose adjustment than with routine titration3.
  • Safety. Proportionally more patients in the JAZZ DoseCoach study arm vs. the control arm achieved target FSMPG without confirmed or severe hypoglycaemia3.
  • Patient-Reported Outcome Patients and healthcare professionals scored the JAZZ DoseCoach device easy to use, with mean scores ≥6 on a 1-7 scale3.

To arrange for an AgaMatrix representative to visit you to demonstrate the JAZZ DoseCoach, please call our Customer Care Team on 0800 093 1812 or email customercare@agamatrix.co.uk

1 With integrated blood glucose meter
2 Using defined treatment plans
3 Davies M, et al. J Diabetes Sci Technol 2019 January 21 ;[Epub Ahead of Print]
All trademarks and trade names are those of their respective owners. DoseCoach® is a registered trademark of Sanofi.